Event Date/Time: May 16, 2005 End Date/Time: May 18, 2005
Report as Spam


The Impurities Conference delivers up-to-the-minute analysis of ICH, FDA and USP guidelines, new strategies for drug development and manufacturing, as well as numerous case studies illustrating the latest in analytical technology and best practice in identifying, isolating and separating impurities and extractables.
Regulatory officials and leading scientists from the following companies will share their challenges and successes in controlling and investigating impurities: Amgen, Baxter Healthcare, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Johnson & Johnson PRD, Merck & Company, Pfizer Global R& D, United States Pharmacopeia, West Pharmaceutical Services, Wyeth Research.